Alto Neuroscience Inc (ANRO) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

ANRO ranks #4225 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ANRO is a top-conviction position for 72 Investment Holdings, LLC — at 35.3% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ANRO belongs to Alpha Wave Global, LP, but the position matters far more to 72 Investment Holdings, LLC, who has 35.3% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

BlackRock has added to its ANRO position for two straight quarters, increasing it by $45.2M to reach $56.0M today.

Alkeon Capital Management LLC has trimmed its ANRO position for two straight quarters, cutting it by $5.8M while still holding $2.7M.

ANRO is up 4.1% today, and institutions have been net buyers of $88.3M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

ANRO reported a net loss of $63.2M in its latest fiscal year.

• Not yet profitable — net loss of $63.2M in the latest fiscal year
• Net income declined year over year, from -$61.4M to -$63.2M
• Operating cash flow was negative, using $51.8M in cash
• Current ratio of 15.69x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.22x equity — within a conventional range